INDO US BIO-TECH | BEEYU OVERSEAS | INDO US BIO-TECH/ BEEYU OVERSEAS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 862.6 | 4.9% | View Chart |
P/BV | x | 8.6 | 19.5 | 44.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH BEEYU OVERSEAS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
BEEYU OVERSEAS Mar-23 |
INDO US BIO-TECH/ BEEYU OVERSEAS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 5 | 2,692.7% | |
Low | Rs | 25 | 2 | 1,388.9% | |
Sales per share (Unadj.) | Rs | 61.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 7.2 | 0 | 113,408.2% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 0 | 34,458.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 0.2 | 28,991.3% | |
Shares outstanding (eoy) | m | 10.03 | 14.14 | 70.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0 | - | |
Avg P/E ratio | x | 10.4 | 522.0 | 2.0% | |
P/CF ratio (eoy) | x | 9.4 | 136.4 | 6.9% | |
Price / Book Value ratio | x | 1.4 | 17.2 | 8.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 46 | 1,651.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 0 | 5,208.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 0 | - | |
Other income | Rs m | 0 | 2 | 13.4% | |
Total revenues | Rs m | 618 | 2 | 39,341.4% | |
Gross profit | Rs m | 94 | -1 | -7,699.2% | |
Depreciation | Rs m | 8 | 0 | 3,304.0% | |
Interest | Rs m | 12 | 0 | - | |
Profit before tax | Rs m | 74 | 0 | 73,870.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 0 | 7,300.0% | |
Profit after tax | Rs m | 72 | 0 | 80,444.4% | |
Gross profit margin | % | 15.2 | 0 | - | |
Effective tax rate | % | 2.0 | 16.2 | 12.2% | |
Net profit margin | % | 11.7 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 15 | 3,954.4% | |
Current liabilities | Rs m | 123 | 1 | 18,912.3% | |
Net working cap to sales | % | 77.1 | 0 | - | |
Current ratio | x | 4.9 | 23.3 | 20.9% | |
Inventory Days | Days | 1 | 0 | - | |
Debtors Days | Days | 146,261,410 | 0 | - | |
Net fixed assets | Rs m | 90 | 17 | 521.9% | |
Share capital | Rs m | 100 | 141 | 70.9% | |
"Free" reserves | Rs m | 445 | -139 | -320.5% | |
Net worth | Rs m | 545 | 3 | 20,564.5% | |
Long term debt | Rs m | 17 | 0 | - | |
Total assets | Rs m | 689 | 32 | 2,129.9% | |
Interest coverage | x | 7.2 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0 | - | |
Return on assets | % | 12.3 | 0.3 | 4,473.3% | |
Return on equity | % | 13.3 | 3.3 | 397.4% | |
Return on capital | % | 15.3 | 4.0 | 386.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 0 | 1,547.1% | |
From Investments | Rs m | -67 | NA | -44,493.3% | |
From Financial Activity | Rs m | 63 | -1 | -10,659.3% | |
Net Cashflow | Rs m | 1 | 0 | -1,281.8% |
Indian Promoters | % | 70.2 | 24.6 | 284.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 75.4 | 39.6% | |
Shareholders | 1,166 | 13,111 | 8.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | BEEYU OVERSEAS |
---|---|---|
1-Day | 8.77% | -4.94% |
1-Month | 26.17% | 13.66% |
1-Year | 113.64% | 83.00% |
3-Year CAGR | 152.58% | 63.33% |
5-Year CAGR | 42.16% | 64.92% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the BEEYU OVERSEAS share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of BEEYU OVERSEAS the stake stands at 24.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of BEEYU OVERSEAS.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
BEEYU OVERSEAS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of BEEYU OVERSEAS.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.